High Dose Pantoprazole for Gastroesophageal Reflux Disease: Need, Evidence, Guidelines and Our Experience-Reference-Cited by-同舟云学术

High Dose Pantoprazole for Gastroesophageal Reflux Disease: Need, Evidence, Guidelines and Our Experience

Published:2024-06-12 Issue:1 Volume:14 Page:86-91
ISSN:2231-5047
Container-title:Euroasian journal of hepato-gastroenterology
language:en
Short-container-title:

Author:

Upadhyay Rajesh,Jaiswal Sunil,Mungantiwar Ashish,Nayar Shreshth,Soni Navin K,Kotamkar Ashwin A,Naseem Azra,Phadke Aaditi,Pallewar Shailesh,Shetty Parvan,Qamra Amit

Publisher

Jaypee Brothers Medical Publishing

Link

https://www.ejohg.com/doi/pdf/10.5005/jp-journals-10018-1426

Reference32 articles.

1. 1. Dawoodi S, Dawoodi I, Dixit P. Gastrointestinal problem among Indian adults: Evidence from longitudinal aging study in India 2017–18. Front Public Health 2022;26(10):911354. DOI: 10.3389/fpubh.2022.911354.

2. 2. Ami D, Sperber AD, Shrikant I, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology 2021;160(1):99–114.e3. DOI: 10.1053/j.gastro.2020.04.014.

3. 3. Al Ghadeer HA, Alabbad ZE, AlShaikh SB, et al. Prevalence of gastroesophageal reflux disease and associated risk factors in the Eastern Region, Saudi Arabia. Cureus 2021;13(11):e19599. DOI: 10.7759/cureus.19599.

4. 4. Chowdhury SD, George G, Ramakrishna K, et al. Prevalence and factors associated with gastroesophageal reflux disease in southern India: A community-based study. Indian J Gastroenterol 2019;38(1):77–82. DOI: 10.1007/s12664-018-00931-6.

5. 5. Rai S, Kulkarni A, Ghoshal UC. Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: A meta-analysis and meta-regression study. Indian J Gastroenterol 2021;40(2):209–219. DOI: 10.1007/s12664-020-01104-0.